Cargando...
Pancreatic cancer, treatment options, and GI-4000
Although pancreatic cancer is but the eleventh most prevalent cancer in the US, it is predicted that of all the patients newly diagnosed with this disease in 2014, only 27% will still be alive at the end of the first year and only 6% will make it past 5 years. The choice of chemotherapy in the treat...
Guardado en:
| Publicado en: | Hum Vaccin Immunother |
|---|---|
| Autores principales: | , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Taylor & Francis
2015
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4514054/ https://ncbi.nlm.nih.gov/pubmed/25585100 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/21645515.2014.1004017 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|